Ditchcarbon
  • Contact
  1. Organizations
  2. CoreRx, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

CoreRx, Inc. Sustainability Profile

Company website

CoreRx, Inc., a leading player in the pharmaceutical contract development and manufacturing industry, is headquartered in the United States. Founded in 2010, the company has established itself as a trusted partner for pharmaceutical and biotechnology firms, specialising in the development and production of complex drug formulations. With a focus on oral solid dosage forms, CoreRx offers a range of services, including formulation development, analytical testing, and commercial manufacturing. Their commitment to innovation and quality has positioned them as a preferred choice for clients seeking tailored solutions in drug development. CoreRx's notable achievements include a robust portfolio of successful product launches and a reputation for excellence in regulatory compliance, making them a key contributor to the advancement of healthcare solutions globally.

DitchCarbon Score

How does CoreRx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

17

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

CoreRx, Inc.'s score of 17 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.

15%

Let us know if this data was useful to you

CoreRx, Inc.'s reported carbon emissions

CoreRx, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that CoreRx, Inc. may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be essential for CoreRx, Inc. to consider developing and communicating its climate commitments to align with broader environmental goals.

How Carbon Intensive is CoreRx, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CoreRx, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is CoreRx, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CoreRx, Inc. is in US, which has a low grid carbon intensity relative to other regions.

CoreRx, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

CoreRx, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare CoreRx, Inc.'s Emissions with Industry Peers

Quotient Sciences Limited

GB
•
Research and development services (73)
Updated 14 days ago

Alcami

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Samsung Biologics

KR
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Evonik

DE
•
Chemicals nec
Updated about 15 hours ago

Corden Pharma GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Frontage Laboratories, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy